Dennis S. Charney
Icahn School of Medicine at Mount Sinai
822 Papers
11.8K Citations
Dennis S. Charney is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Anxiety & Medicine. The author has an hindex of 179, co-authored 802 publications. Previous affiliations of Dennis S. Charney include Mount Sinai Hospital & Veterans Health Administration.
Chat about Author
Papers
Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress.
C A Morgan rd,Shuang Wang,Ann M. Rasmusson,Gary Hazlett,George M. Anderson,Dennis S. Charney +5 more
TL;DR: The data suggest that some biological differences may exist before index trauma exposure and before the development of stress-related illness.
203
Brain derived neurotrophic factor (BDNF) gene variants and Alzheimer's disease, affective disorders, posttraumatic stress disorder, schizophrenia, and substance dependence.
Huiping Zhang,Fatih Ozbay,Jaakko Lappalainen,Henry R. Kranzler,Christopher H. van Dyck,Dennis S. Charney,Lawrence H. Price,Steven M. Southwick,Bao-Zhu Yang,Ann Rasmussen,Joel Gelernter +10 more
TL;DR: A modest association between SNP G−712A and substance dependence is confirmed and the negative results for AFDs, PTSD, and schizophrenia could be due to the low statistical power.
•Book
Resilience: The Science of Mastering Life's Greatest Challenges
Steven M. Southwick,Dennis S. Charney +1 more
- 01 Jul 2012
TL;DR: In this paper, the authors provide a guide to building emotional, mental and physical resilience by presenting ten factors to help anyone become more resilient to life's challenges, such as facing fear, optimism, and social support.
201
Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.
TL;DR: Elevated levels of central interleukin-2 might contribute to the increased dopaminergic neurotransmission, autoimmune phenomena, and abnormal brain morphology described in some patients with schizophrenia.
199
Carbon dioxide sensitivity in panic anxiety. Ventilatory and anxiogenic response to carbon dioxide in healthy subjects and patients with panic anxiety before and after alprazolam treatment.
Scott W. Woods,Dennis S. Charney,Jacob Loke,Wayne K. Goodman,D. Eugene Redmond,George R. Heninger +5 more
TL;DR: Differences in anxiogenic sensitivity to CO2 between patients and controls may be due to differences in the regulation of noradrenergic or other neuronal systems.
196